Cytoplasmic tyrosine kinase c-Abl is required for bFGF but not VEGF-induced tumor angiogenesis
Publication
, Conference
Shao, R; Yan, W; Pazik, B; Pendergast, AM; Wang, X-F
Published in: CANCER RESEARCH
April 1, 2006
Duke Scholars
Published In
CANCER RESEARCH
EISSN
1538-7445
ISSN
0008-5472
Publication Date
April 1, 2006
Volume
66
Issue
8
Publisher
AMER ASSOC CANCER RESEARCH
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Shao, R., Yan, W., Pazik, B., Pendergast, A. M., & Wang, X.-F. (2006). Cytoplasmic tyrosine kinase c-Abl is required for bFGF but not VEGF-induced tumor angiogenesis. In CANCER RESEARCH (Vol. 66). AMER ASSOC CANCER RESEARCH.
Shao, Rong, Wei Yan, Brooke Pazik, Ann Marie Pendergast, and Xiao-Fan Wang. “Cytoplasmic tyrosine kinase c-Abl is required for bFGF but not VEGF-induced tumor angiogenesis.” In CANCER RESEARCH, Vol. 66. AMER ASSOC CANCER RESEARCH, 2006.
Shao R, Yan W, Pazik B, Pendergast AM, Wang X-F. Cytoplasmic tyrosine kinase c-Abl is required for bFGF but not VEGF-induced tumor angiogenesis. In: CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2006.
Shao, Rong, et al. “Cytoplasmic tyrosine kinase c-Abl is required for bFGF but not VEGF-induced tumor angiogenesis.” CANCER RESEARCH, vol. 66, no. 8, AMER ASSOC CANCER RESEARCH, 2006.
Shao R, Yan W, Pazik B, Pendergast AM, Wang X-F. Cytoplasmic tyrosine kinase c-Abl is required for bFGF but not VEGF-induced tumor angiogenesis. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2006.
Published In
CANCER RESEARCH
EISSN
1538-7445
ISSN
0008-5472
Publication Date
April 1, 2006
Volume
66
Issue
8
Publisher
AMER ASSOC CANCER RESEARCH
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis